featured
Role of Consolidation Durvalumab in EGFR- and HER2-Mutant Unresectable Stage III NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brief Report: Role of Consolidation Durvalumab in Patients With EGFR and HER2 Mutant Unresectable Stage III NSCLC
J Thorac Oncol 2021 Feb 01;[EPub Ahead of Print], JA Hellyer, JV Aredo, M Das, K Ramchandran, SK Padda, JW Neal, HA WakeleeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.